Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus.

Park JW, Yoon J, Cho CK, Lee YW, Yoo HS.

Chin J Integr Med. 2014 Jan;20(1):49-55. doi: 10.1007/s11655-012-1084-0. Epub 2012 May 19.

PMID:
22610951
2.

[Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].

Zhao AG, Cao W, Xu Y, Zhao G, Liu BY, Cai Y, Yang JZ, Gu Y, Yuan W, Zhu YJ, Han YY, Yang JY.

Zhong Xi Yi Jie He Xue Bao. 2010 Mar;8(3):224-30. Chinese.

3.

A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus.

Bang SH, Yoon JW, Cho CK, Shin JE, Lee YW, Yoo HS.

J Pharmacopuncture. 2012 Jun;15(2):31-5. doi: 10.3831/KPI.2012.15.2.031.

4.

A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.

Tural D, Selçukbiricik F, Serdengeçti S, Büyükünal E.

World J Surg Oncol. 2012 Nov 2;10:234. doi: 10.1186/1477-7819-10-234.

5.

Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?

Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP.

J Surg Oncol. 2007 Feb 1;95(2):118-22.

PMID:
17262741
6.
7.

Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy.

Kim KH, Lee KW, Baek SK, Chang HJ, Kim YJ, Park do J, Kim JH, Kim HH, Lee JS.

Gastric Cancer. 2011 Jun;14(2):130-8. doi: 10.1007/s10120-011-0015-7. Epub 2011 Mar 4.

PMID:
21373855
8.

One-day DCF regimen in patients with metastatic gastric cancer.

Dirican A, Kucukzeybek Y, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Akyol M, Ekinci N, Medeni M, Koyuncu B, Alacacioglu A.

Tumori. 2013 Mar-Apr;99(2):145-8. doi: 10.1700/1283.14183.

PMID:
23748805
9.

Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen.

Tomasello G, Chiesa MD, Buti S, Brighenti M, Negri F, Rovere RK, Martinotti M, Buononato M, Brunelli A, Lazzarelli S, Donati G, Passalacqua R.

Tumori. 2010 Jan-Feb;96(1):48-53.

10.

[Docetaxel-cisplatin-5-FU combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric cancer].

Kang SH, Kim JI, Goh PG, Hwang SW, Kwon DS, Nam KW, Kang HM, Kang YS, Moon HS, Kim SH, Seong JK, Lee BS, Jeong HY.

Korean J Gastroenterol. 2007 Sep;50(3):157-63; discussion 207-9. Korean.

11.

Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) for patients with advanced gastric cancer.

Xu Y, Zhao AG, Li ZY, Zhao G, Cai Y, Zhu XH, Cao ND, Yang JK, Zheng J, Gu Y, Han YY, Zhu YJ, Yang JZ, Gao F, Wang Q.

Integr Cancer Ther. 2013 Sep;12(5):414-22. doi: 10.1177/1534735412450512. Epub 2012 Jul 9.

PMID:
22781545
12.
13.

[Clinical analysis of the current treatment status of gastric cancer in 636 patients].

Zhuang QX, Xu JM, Lin L, Ge FJ, Liu LJ, Wang Y, Zhao CH.

Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):316-20. doi: 10.3760/cma.j.issn.0253-3766.2012.04.017. Chinese.

PMID:
22781048
14.
15.

[The treatment of gastric carcinoma in III stage].

Lin C, Zhu X, Chai Z.

Zhonghua Wai Ke Za Zhi. 1995 Sep;33(9):548-50. Chinese.

PMID:
8731875
16.

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Cho SH, Chung IJ.

BMC Cancer. 2011 Nov 21;11:489. doi: 10.1186/1471-2407-11-489.

17.

[Prognostic analysis of advanced non small cell lung cancer treated by sequential chemo-radiation therapy combined with traditional Chinese medicine: a report of 54 cases].

Han MQ, Su JM, Huang HY, Long WH, Qin LP, Qin P, Liu W, Sheng ZY.

Zhong Xi Yi Jie He Xue Bao. 2003 Sep;1(3):195-8. Chinese.

18.

Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.

Seo HY, Kim DS, Choi YS, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.

Cancer Chemother Pharmacol. 2009 Feb;63(3):433-9. doi: 10.1007/s00280-008-0753-3. Epub 2008 Apr 9.

PMID:
18398608
19.

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma.

Lee J, Lim T, Uhm JE, Park KW, Park SH, Lee SC, Park JO, Park YS, Lim HY, Sohn TS, Noh JH, Heo JS, Park CK, Kim S, Kang WK.

Ann Oncol. 2007 May;18(5):886-91. Epub 2007 Feb 13.

20.

[Evaluation of S-1 for stage IV gastric cancer].

Kanazawa Y, Furukawa K, Yamada T, Shirakawa T, Fujita I, Kato S, Yokoi K, Uchida E.

Gan To Kagaku Ryoho. 2011 Oct;38(10):1619-22. Japanese.

PMID:
21996955
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk